PERMIT WP5 hosted its third virtual working session, with a focus on animal models for personalised medicine, on June 22nd. The group consisted of nine experts from various aspects of modelling human disease in animals, including a patient representative. The discussion topics related to evidence-based methods and quality control of animal experiments, with an emphasis on relevance for patients. Accurate reporting is essential, increased transparency and preregistration of animal experiments was advocated. The outcome of this meeting will be discussed further in a dedicated workshop titled “Recommendations for more robust and reproducible preclinical research in personalised medicine” scheduled for Wednesday, September 1st.
On July 7 the #PERMITproject held its General Assembly. It was an opportunity to reflect on the achievements of the past 6 months, as efforts shift towards drafting recommendations on #personalisedmedicine research. Learn more: permit-eu.org/article/3rd-pe… https://t.co/MAfW1CcOeF
#CellularModels for #PersonalisedMedicine were the final topic in the #PERMITproject series on #preclinical methods for personalised medicine on 30 June. Read more about the session and outcomes here: permit-eu.org/article/focus-… ECRIN_ERIC https://t.co/DoAx6i9KoE